Hussein Tawbi, a Professor at The University of Texas MD Anderson Cancer Center shared a post on LinkedIn:
“Expertly presented EADO 2026 by Liz Burton, PhD, MBA: planned interim results of BLUEBONNET 50% intracranial response to Nivo+Rela in active Melanoma Brain Mets, excellent safety.
Highlighted role of Andrew M. McDougall Brain Metastasis Clinic in multidisciplinary care, trial ongoing.”
Other articles featuring Hussein Tawbi on OncoDaily.
